Sonoma Pharmaceuticals (SNOA) Net Income towards Common Stockholders Growth (5y) (2015 - 2025)
Sonoma Pharmaceuticals (SNOA) Net Income towards Common Stockholders Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Sonoma Pharmaceuticals | 1.87 Mn | -693,829.94 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -102.59% |
| Sep 30, 2025 | -76.70% |
| Jun 30, 2025 | -27.03% |
| Mar 31, 2025 | -128.06% |
| Dec 31, 2024 | -56.42% |
| Sep 30, 2024 | -55.79% |
| Jun 30, 2024 | -97.27% |
| Mar 31, 2024 | 16.70% |
| Dec 31, 2023 | 17.89% |
| Sep 30, 2023 | 10.69% |
| Jun 30, 2023 | 16.57% |
| Sep 30, 2021 | -16.49% |
| Jun 30, 2021 | -30.42% |
| Dec 31, 2020 | -15.13% |
| Sep 30, 2020 | 55.90% |
| Jun 30, 2020 | 19.24% |
| Mar 31, 2020 | 14.96% |
| Dec 31, 2019 | 15.60% |
| Sep 30, 2019 | 15.49% |
| Jun 30, 2019 | 15.18% |